Got questions about navigating life with diabetes? Welcome to our weekly advice column, Ask D’Mine – the place to get some colorful answers from veteran type 1, diabetes author and educator, Wil Dubois.
This week, Wil takes a look at the perennial question of a “diabetes conspiracy”: does Big Pharma really have our best interests in mind as it goes about the business of selling treatments?
{Got your own questions? Email us at AskDMine@diabetesmine.com}
…
Read more »
Just a few short years ago, no one could have envisioned the Diabetes Online Community would become what it is today. And be moving in the collaborative direction it’s going…
Seriously, some likely would have laughed at the idea while shaking their heads in disbelief!
It used to be “Us versus Them,” in terms of the relationship between Pharma and people with diabetes (PWDs). There was little interaction; we didn’t know them and they didn’t…
Read more »
Sometimes, diabetes science confuses me.
Let’s take the news of an emerging class of diabetes drugs (type 2-focused) that apparently do something we’ve always thought was bad… but it’s actually not.
Sodium-glucose transporter (SGLT-2) inhibitors increase insulin production and effectiveness and stop the liver from producing too much glucose. Basically, they work by spilling glucose over into the urine which leads to less sugar in your bloodstream. The effect: lower BGs and A1Cs.
Sure, it…
Read more »
As the Diabetes Social Media Summit hosted by Roche approaches, I’ve been thinking and reading a lot about the question of Pharma engagement here. Is Social Media destined to be just another forum for them to push marketing mantras and build brands? Or can there really be valuable two-way interaction between the chronically drug-dependent (us PWDs, for example) and the industry that sells us our meds?
A whole lot of blogosphere debate is going on,…
Read more »
By
AmyT on
October 29, 2008
I met Alexis at the recent BDI luncheon for women with Type 1 diabetes. She seemed bubbly and smart, and I felt an instant connection. When I discovered her job title was “Compliance Analyst,” I just had to hear more about that. Turns out it’s not quite what you think, but fascinating nevertheless.
A Guest Post by Alexis Pollack —
Compliance Analyst, Amylin Pharmaceuticals, Inc.
Type 1 diabetes for 15 years
Compliance. It’s not a…
Read more »
